Hims stock tanks over 20% after Wegovy deal collapse — why Novo Nordisk’s breakup over weight loss drugs i
The Economic Timesarrow_outwardNovo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
PR Newswirearrow_outwardNovo Nordisk exits obesity-drug partnership with Hims & Hers, cites compounding concerns
Mintarrow_outwardNovo Nordisk launches blockbuster weight-loss drug Wegovy in India - Business Standard
Business Standardarrow_outwardNovo Nordisk launches blockbuster weight-loss drug Wegovy in India - MSN
MSNarrow_outwardNovo Nordisk Launches Weight-Loss Drug 'Wegovy' In India - NDTV
NDTVarrow_outwardNovo Nordisk Launches Weight-Loss Drug Wegovy, Months After Lilly, in Obesity-Hit India - Bloomberg
Bloombergarrow_outwardNovo Nordisk launches anti-obesity drug Wegovy in India at Rs 4,336.25 per dose - Business Today
Business Todayarrow_outwardNovo Nordisk Launches Weight-Loss Drug Wegovy In India Starting From Rs 17,300 - NDTV Profit
NDTV Profitarrow_outwardNovo Nordisk launches blockbuster weight loss drug Wegovy in India - CNBC TV18
CNBC TV18arrow_outwardNovo Nordisk launches blockbuster weight-loss drug Wegovy in India - MarketScreener
MarketScreenerarrow_outwardNovo Nordisk launches blockuster weight-loss drug Wegovy in India - TradingView
TradingViewarrow_outwardWegovy, widely popular weight-loss drug, launched in India: Price, dosage - India Today
India Todayarrow_outwardDanish firm Novo Nordisk set to launch Wegovy in India for weight loss - BusinessLine
BusinessLinearrow_outwardWegovy, the global sensation in obesity management, launched in India - ThePrint
ThePrintarrow_outwardBig Pharma Faceoff: Wegovy To Join Mounjaro In India’s Booming Weight Loss Drug Market - News18
News18arrow_outwardHims & Hers stock plunges after Novo Nordisk ends its brief partnership - Business Insider
Business Insiderarrow_outwardNovo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds - ABC News - Breaking News, Latest News and Videos
ABC News - Breaking News, Latest News and Videosarrow_outwardWegovy Partnership Unravels as Novo Nordisk, Hims & Hers Trade Accusations - Athletech News
Athletech Newsarrow_outwardHims Crashes After Novo Unexpectedly Yanks Collaboration Deal - Investor's Business Daily
Investor's Business Dailyarrow_outwardNovo, Hims & Hers engage in war of words after Wegovy deal falls apart - Reuters
Reutersarrow_outwardNovo Nordisk Abruptly Ends Partnership with Hims, Claiming 'Sham Compounding' GLP-1 Drugs - Gizmodo
Gizmodoarrow_outwardNovo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices - CBS News
CBS Newsarrow_outwardHims & Hers stock plummets after Novo Nordisk ends partnership over ‘knockoff’ Wegovy - Fast Company
Fast Companyarrow_outwardNovo Nordisk ends partnership with Hims & Hers over Wegovy copycats - The Hill
The Hillarrow_outwardNovo Nordisk Cuts Wegovy Deal, Triggers Massive Selloff in Hims & Hers - Yahoo Finance
Yahoo Financearrow_outwardNovo Nordisk halts Wegovy deal with Hims & Hers, triggering 31% stock drop - USA Today
USA Todayarrow_outwardNovo Nordisk Ends Hims & Hers Partnership Over Wegovy Sales - Finimize
Finimizearrow_outwardNovo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing" - AOL.com
AOL.comarrow_outwardNovo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs - Financial Times
Financial Timesarrow_outwardHims & Hers stock plunges 30% as Novo Nordisk terminates Wegovy direct sales deal - Fierce Healthcare
Fierce Healthcarearrow_outwardHims Stock Sinks 30% as Novo Nordisk Ends Wegovy Deal - Colitco
Colitcoarrow_outwardNovo abruptly ends obesity drug deal with Hims - BioPharma Dive
BioPharma Divearrow_outwardNovo ends short-lived partnership with Hims over compounded obesity drugs - Endpoints News
Endpoints Newsarrow_outwardMounjaro and Wegovy demand helps Chemist4U sales double - City AM
City AMarrow_outwardEli Lilly drug bimagrumab saves muscle mass when added to Novo's Wegovy - Seeking Alpha
Seeking Alphaarrow_outwardWegovy manufacturer ends deal with Hims & Hers to distribute weight loss drug - The Independent
The Independentarrow_outwardHims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company. - MarketWatch
MarketWatcharrow_outwardNovo Nordisk cuts off Hims & Hers over knockoff Wegovy — and the stock plummets 27% - Quartz
Quartzarrow_outwardNovo ends partnership with Hims & Hers over compounding concerns - Axios
Axiosarrow_outwardPopular weight loss drugs like Wegovy, Zepbound remain unaffordable for many in need - News Channel 6 | Wichita Falls, TX
News Channel 6 | Wichita Falls, TXarrow_outwardNovo Nordisk and Hims & Hers Health End Wegovy Partnership - News and Statistics - IndexBox
IndexBoxarrow_outwardEli Lilly drug preserves lean mass in patients losing weight on Wegovy - STAT
STATarrow_outwardNovo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34% - CNBC
CNBCarrow_outwardNovo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20% - NBC Connecticut
NBC Connecticutarrow_outwardNovo Nordisk’s New Obesity Drug Beats Wegovy Weight Loss in Early Trial - WSJ
WSJarrow_outwardNovo Nordisk publishes data on higher dose of Wegovy - medwatch.com
Medwatch.comarrow_outwardHigh-dose Wegovy cuts weight 21%, new data shows - The Pharma Letter
The Pharma Letterarrow_outwardNew weight-loss drug is ‘better than Wegovy’ — and comes in a pill - The Times
The Timesarrow_outward4 FDA-Approved Weight Loss Medications, According To Experts - Forbes
Forbesarrow_outwardNovo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee - Fortune
Fortunearrow_outwardA new chapter for online sales of obesity drug alternatives tests legal limits - NPR
NPRarrow_outwardDry mouth, bad breath and tooth damage: the effects Ozempic and Wegovy can have on your mouth - The Conversation
The Conversationarrow_outwardNew Research Reveals Most Effective Obesity Drug: It’s Not Ozempic or Wegovy - SciTechDaily
SciTechDailyarrow_outwardAs costs of weight loss drugs like Wegovy and Zepbound go down, how low can prices go? - NBC News
NBC Newsarrow_outwardNovo Nordisk to launch blockbuster obesity drug Wegovy in India soon - Moneycontrol
Moneycontrolarrow_outwardStudy directly compares Zepbound and Wegovy for weight-loss results - Fox News
Fox Newsarrow_outwardZepbound or Wegovy? Head-to-Head Trial Says One Is Better for Weight Loss - health.com
Health.comarrow_outwardFDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know - Healthline
Healthlinearrow_outwardZepbound outduels Wegovy in weight-loss clinical trial - Cornell Chronicle
Cornell Chroniclearrow_outwardMounjaro vs Wegovy: Weight-loss drugs in head-to-head trial - BBC
BBCarrow_outwardWhy Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug - The New York Times
The New York Timesarrow_outwardZepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine - Eli Lilly
Eli Lillyarrow_outwardZepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs - AP News
AP Newsarrow_outwardSURMOUNT-5: Tirzepatide (Zepbound) Proves Benefit over Semaglutide (Wegovy) for Obesity - HCPLive
HCPLivearrow_outwardWegovy maker Novo Nordisk cuts profit forecast as US prescriptions tail off - The Guardian
The Guardianarrow_outwardNovo Nordisk Partners With Telehealth Platforms to Expand Wegovy Access - The Cardiology Advisor
The Cardiology Advisorarrow_outwardWegovy is now just a click away: What you should know about this popular weight loss drug and the red fla - Times of India
Times of Indiaarrow_outwardDrugs like Wegovy can be effective at treating fatty liver disease - New Scientist
New Scientistarrow_outwardNovoCare Pharmacy may improve access to Wegovy, but concerns about affordability remain - Healio
Healioarrow_outwardOnce-Weekly Semaglutide in Adults with Overweight or Obesity - The New England Journal of Medicine
The New England Journal of Medicinearrow_outward
Wegovy close
- 2025-06-24 16:00 event
- 71 sourceslanguage
- 200+ ads_click
- 1 week ago schedule